Drug testing is an objective measure at a therapeutic exchange where uncertainty can prevail. A single individual drug test empowers both the patient and provider to overcome barriers of doubt, denial, and stigma that can at times accompany patients suffering from or at risk for Substance Use Disorders. It can support patients who are forging ahead in their path to recovery.
"A single individual drug test empowers both the patient and provider"
Urine Drug Testing
Aspenti Health is home to a state-of-the art laboratory in Vermont that process urine drug screens in 24 hours, with a 48-hour turnaround for drug confirmations. Aspenti assists providers in creating customized patient-specific profiles to assist with patient care, along with providing guidance on medically necessary testing. Aspenti offers an extensive urine drug testing menu featuring over 70 drugs and metabolites.
Our digital portal, LabPartner, makes it easy to order tests and retrieve results online as provides access to robust graphical reporting tools that save time and provide valuable insights to enhance patient care. The system offers complete ordering flexibility while empowering providers to chart the history of a single drug analyte over the entire course of treatment and to analyze patient progress while quickly identifying any abnormalities. Additionally, a specimen cup label prints with every order to ensure that the sample matches the requisition when it arrives at the lab, eliminating the need for handwritten labels or paper requisitions. We also offer additional reporting capabilities for Substance Abuse Management and Prescription Assessments.
Aspenti Health’s Comprehensive Screen provides superior first-time results by leveraging LC/MS/MS technology. Our AMA approved proprietary laboratory analyses (PLA) provides a wider spectrum of analytes with increased screen accuracy, decreased false positive and false negatives in a 24 hour turnaround time. Our latest testing innovation continues to address the clinical and financial barriers of the current testing paradigm supporting the right patient care, at the right time, and at the right cost. Faster results lead to faster care and earlier intervention which decreases diversion, relapse, and overdose risk while decreasing expensive and acute follow-up care. For more information, please contact email@example.com.